A recent study found that ROS levels in thyroid cancer cells decreased after 24 h of treatment with 20–50 μM NaHS, which activated the PI3K/AKT/mTOR signalling pathway to promote tumour cell proliferation and migration25. The gene discussed is MTOR; the disease is thyroid gland carcinoma.